Checkpoint Therapeutics Inc [CKPT] stock prices are down -6.80% to $3.29 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The CKPT shares have gain 15.85% over the last week, with a monthly amount drifted -4.36%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Checkpoint Therapeutics Inc [NASDAQ: CKPT] stock has seen the most recent analyst activity on January 13, 2025, when D. Boral Capital initiated its Buy rating and assigned the stock a price target of $9. On June 09, 2021, B. Riley Securities initiated with a Buy rating and assigned a price target of $18 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $16 on January 20, 2021. Lake Street initiated its recommendation with a Buy. H.C. Wainwright started tracking with a Buy rating for this stock on December 08, 2017, and assigned it a price target of $11.
The stock price of Checkpoint Therapeutics Inc [CKPT] has been fluctuating between $1.38 and $4.50 over the past year. Checkpoint Therapeutics Inc [NASDAQ: CKPT] shares were valued at $3.29 at the most recent close of the market.
Analyzing the CKPT fundamentals
The Checkpoint Therapeutics Inc [NASDAQ:CKPT] reported sales of 0.05M for trailing twelve months, representing a drop of -100.00%. Gross Profit Margin for this corporation currently stands at -451.68% with Operating Profit Margin at -798.17%, Pretax Profit Margin comes in at -988.68%, and Net Profit Margin reading is -988.68%. To continue investigating profitability, this company’s Return on Assets is posted at -8.97, Equity is 3.6 and Total Capital is 2.98.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.18 points at the first support level, and at 3.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.48, and for the 2nd resistance point, it is at 3.67.
Ratios To Look Out For
It’s worth pointing out that Checkpoint Therapeutics Inc [NASDAQ:CKPT]’s Current Ratio is 0.29. On the other hand, the Quick Ratio is 0.29, and the Cash Ratio is 0.26. Considering the valuation of this stock, the price to sales ratio is 3213.20.
Transactions by insiders
Recent insider trading involved GRAY WILLIAM GARRETT, Chief Financial Officer, that happened on Feb 06 ’25 when 74110.0 shares were sold. CEO, President and Director, Oliviero James F III completed a deal on Dec 18 ’24 to sell 0.6 million shares. Meanwhile, CEO, President and Director Oliviero James F III sold 0.22 million shares on Dec 19 ’24.
